Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Digestive System Drugs > Ursodeoxycholic acid for Sale > USP BP EP standard Ursodeoxycholic 98% white powder GMP manufacturer
USP BP EP standard Ursodeoxycholic 98% white powder  GMP manufacturer buy - large image1
USP BP EP standard Ursodeoxycholic 98% white powder  GMP manufacturer buy - image1

USP BP EP standard Ursodeoxycholic 98% white powder GMP manufacturer

13 Inquiries

Unit Price: Get Latest Price
CAS No.:

128-13-2

Grade:

Pharmaceutical Grade

Content:

98%

Brand:

Xieli

Packaging:

25kg/ drum

Price valid (until):

2023-06-29

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

dasatinib,ingenol mebutate,hesperidin,irinotecan HCL,erlotinib,nastrozole

  • Product Description

  • Seller Information

  • Inquiry History

  • Description
    ItemsResults
    Molecula FomulaC24H40O4
    CAS 128-13-2
    Appearancewhite powder
    Melting Point203ºC~ 206ºC
    Assay≥ 98%


    Ursodeoxycholic acid, chemical name 3a, 7 β- Dihydroxy-5 β- Cholestane-24-acid

    is an organic compound, odorless and bitter. Medically, it is used to increase the

    secretion of bile acids, change the composition of bile, reduce cholesterol and

    cholesterol lipids in bile, and is conducive to the gradual dissolution of cholesterol in gallstones.


    About us

    Xieli Pharm was Founded in 1980's With cGMP\ EU GMP\ Japan GMP certified factory and independent R&D center.
    Irinotecan certificated with Japan GMP and EU GMP. Rutin and Troxerutin certificated with EU-GMP, CEP for Diosmin and Troxerutin
    OEM for plant extracting and TCM Processing CDMO for Process Development, Intermidate, APIs, Formulation and Clinic Study.

    Basic Info
    Product Name:

    Ursodeoxycholic acid

    Other Name:

    Cholan-24-oic acid,3,7-dihydroxy-,(3α,5β,7β)-;5β-Cholan-24-oic acid,3α,7β-dihydroxy-;5β-Cholanic acid,3α,7β-dihydroxy-;(3α,5β,7β)-3,7-Dihydroxycholan-24-oic acid;17β-(1-Methyl-3-carboxypropyl)etiocholane-3α,7β-diol;Ursocholic acid,deoxy-;Ursodeoxycholic acid;Ursodesoxycholic acid;3α,7β-Dihydroxy-5β-cholan-24-oate;3α,7β-Dihydroxycholanic acid;3α,7β-Dihydroxy-5β-cholanic acid;3α,7β-Dihydroxy-5β-cholanoic acid;7β-Hydroxylithocholic acid;3α,7β-Dihydroxy-5β-cholan-24-oic acid;Urso;Actigall;Ursodiol;Deursil;Desocol;Ursofalk;Ursochol;Cholit-Ursan;Ursacol;Destolit;Paptarom;Arsacol;Urdes;Solutrat;Lyeton;Ursobilin;Ursolvan;Ursodamor;Delursan;Desol;Litursol;NSC 683769;Adursal;UDCA;Ursic acid;Ursosan;Ursocol;Ursogall;Urosiol;50809-41-1;80225-86-1;2599839-20-8

    CAS No.:

    128-13-2

    Molecular Formula:

    C24H40O4

    InChIKeys:

    InChIKey=RUDATBOHQWOJDD-UZVSRGJWSA-N

    Molecular Weight:

    392.57200

    Exact Mass:

    392.57

    EC Number:

    204-879-3

    UNII:

    724L30Y2QR

    DSSTox ID:

    DTXSID6023731

    NCI Thesaurus Code:

    C1818

    ATC Code:

    A05AA02|A - Alimentary tract and metabolism

    HScode:

    2918199090

    Characteristics
    PSA:

    77.76000

    XLogP3:

    4.47790

    Appearance:

    Solid

    Density:

    1.128 g/cm3

    Melting Point:

    203 °C

    Boiling Point:

    547.1ºC at 760mmHg

    Flash Point:

    298.8ºC

    Refractive Index:

    1.543

    Water Solubility:

    ethanol: 50 mg/mL, clear

    Storage Conditions:

    Store in a tightly closed container. Store in a cool, dry area away from incompatible substances.

    Vapor Pressure:

    0mmHg at 25°C

    Collision Cross Section:

    208.98 Ų [M-H]- [CCS Type: DT, Method: stepped-field]|198.7 Ų [M+Na]+ [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|200.9 Ų [M-H]- [CCS Type: DT, Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]|198.3 Ų [M-H]- [CCS Type: DT, Method: single field calibrated]|186.8 Ų [M+H-2H2O]+ [CCS Type: DT, Method: single field calibrated]|200.2 Ų [M+HCOO]- [CCS Type: DT, Method: single field calibrated]|205.7 Ų [M+K-H+HCOO]- [CCS Type: DT, Method: single field calibrated]|199.4 Ų [M+Na-H+Cl]- [CCS Type: DT, Method: single field calibrated]|203.2 Ų [M+Na-H+HCOO]- [CCS Type: DT, Method: single field calibrated]

    Hazard Identification

    Classification of the substance or mixture

    Skin irritation, Category 2

    Eye irritation, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H315 Causes skin irritation

    H319 Causes serious eye irritation

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P302+P352 IF ON SKIN: Wash with plenty of water/...

    P321 Specific treatment (see ... on this label).

    P332+P317 If skin irritation occurs: Get medical help.

    P362+P364 Take off contaminated clothing and wash it before reuse.

    P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

    Storage

    none

    Disposal

    none

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    dasatinib,ingenol mebutate,hesperidin,irinotecan HCL,erlotinib,nastrozole

    Location:

    NO.588, middle section of mudan avenue

    Payment Terms:

    TT against copy of documents,L/C

    Average lead Time:

    15

    Total Annual Revenue:

    Above $100 million

    Total Employees:

    501-1000

    Year of Establishment:

    1992

    Company Profile
    Xieli Pharm was founded in 1980's with cGMP\ EU GMP\ Japan GMP certified factory and independent R&D center. Irinotecan certificated with Japan GMP and EU GMP. Rutin and Troxerutin certificated with EU-GMP; CEP for Diosmin and Troxerutin OEM for plant extracting and TCM Processing CDMO for Process Development, Intermidate, APIs, Formulation and Clinic Study.
  • Inquiry History
    13 Inquiries
    Country Product Purchase Quantity Date Posted
    India

    URSODEOXYCHOLIC ACID

    10.00 KG Mar 6, 2024
    Canada

    URSODEOXYCHOLIC AC

    1.5 MT Apr 25, 2026
    United States

    Ursodeoxycholic acid

    500 G Sep 16, 2025
    Lesotho

    Ursodeoxycholic Acid

    1 TON May 21, 2025
    Finland

    Ursodeoxycholic acid

    100 G Mar 21, 2025
    India

    URSODEOXYCHOLIC ACID

    300.00 KG Sep 10, 2024
    India

    udca

    25 KG Sep 11, 2023
    India

    URSODEOXYCHOLIC ACID

    500.00 KG Jul 26, 2024
    India

    Ursodeoxycholic Acid

    1500 KG May 17, 2024
    Brazil

    ACIDO URSODESOXICOLICO

    5.00 KG Jun 28, 2023
    India

    Acarbose

    10.00 KG Mar 6, 2024
    India

    Upadacitinib

    10.00 KG Mar 6, 2024
    India

    Ripretinib

    10.00 KG Mar 6, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.